PubRank

M A Modica

Author PubWeight™ 13.54‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Biological significance of soluble IL-2 receptor. Mediators Inflamm 1993 1.33
2 In vitro cytokine production by HLA-B8,DR3 positive subjects. Autoimmunity 1994 1.05
3 Interleukin 2 and soluble interleukin 2-receptor secretion defect in vitro in newly diagnosed type I diabetic patients. Diabetes 1989 0.97
4 Major histocompatibility complex regulation of cytokine production. J Interferon Cytokine Res 1996 0.92
5 gamma-Interferon, interleukin-4 and interleukin-6 in vitro production in old subjects. Autoimmunity 1993 0.89
6 Blood antiphospholipid antibody levels are influenced by age, sex and HLA-B8,DR3 phenotype. Exp Clin Immunogenet 1992 0.83
7 Dissociated production of interleukin-2 and immune gamma-interferon by phytohaemoagglutinin stimulated peripheral mononuclear cells in type 1 (insulin-dependent) diabetes. J Clin Lab Immunol 1988 0.80
8 Modification of cytokine patterns in subjects bearing the HLA-B8,DR3 phenotype: implications for autoimmunity. Cytokines Cell Mol Ther 1997 0.79
9 Biological basis of the HLA-B8,DR3-associated progression of acquired immune deficiency syndrome. Pathobiology 1998 0.78
10 Natural killer and lymphokine-activated killer activity in HLA-B8,DR3-positive subjects. Hum Immunol 1993 0.78
11 The effect of age on mitogen responsive T cell precursors in human beings is completely restored by interleukin-2. Mech Ageing Dev 1992 0.78
12 Soluble interleukin-2 receptor release defect in vitro in elderly subjects. Mech Ageing Dev 1991 0.76
13 MHC-linked genetic factors (HLA-B35) influencing recurrent circumoral herpetic lesions. Dis Markers 1987 0.76
14 Soluble interleukin-2 receptor in vitro production by mononuclear cells from Hodgkin patients. Boll Ist Sieroter Milan 1990 0.76
15 HLA-DR3 and immunoresponsiveness. Lancet 1990 0.75
16 In vitro T cell activation in elderly individuals: failure in CD69 and CD71 expression. Mech Ageing Dev 1996 0.75
17 HLA-B8,DR3 T cell impairment is completely restored by in vitro treatment with interleukin-2. Immunopharmacol Immunotoxicol 1991 0.75
18 Immunoglobulin heavy-chain allotypes play a role in the clinical history of celiac disease. Exp Clin Immunogenet 1991 0.75
19 [Characterization of cell suspensions adhering to nylon obtained from mononuclear cells in toto or depleted of monocytes]. Boll Soc Ital Biol Sper 1984 0.75
20 HLA antigens in Sicilian patients affected by chronic myelogenous leukaemia. J Immunogenet 1987 0.75
21 Immunoglobulin heavy chain allotypes in a sample of Sicilian patients with celiac disease. Exp Clin Immunogenet 1991 0.75
22 HLA-DR1 and HLA-DR3 phenotypes and insulin antibody production in diabetic Sicilian patients. Exp Clin Immunogenet 1988 0.75
23 In vitro thymopentin modulation of mitogen responsive T-cell precursor frequency. Thymus 1991 0.75
24 IgD serum levels are influenced by HLA-DR phenotype. Dis Markers 1993 0.75
25 In vitro impairment of interleukin-5 production in HLA-B8, DR3-positive individuals implications for immunoglobulin A synthesis dysfunction. Hum Immunol 1995 0.75
26 HLA-DR-linked genes are involved in the control of T lymphocyte blood levels. Clin Immunol Immunopathol 1987 0.75
27 HLA-Cw4 association with acute lymphoblastic leukaemia in Sicilian patients. Vox Sang 1988 0.75